A healthcare company trying to launch a new headache curing drug. Should or shouldn't they invest when they already have a general painkiller in the market
Back to overview
18
How would I approach this? Possible Framework?
2
4.3k
Be the first to answer!
Nobody has responded to this question yet.
Top answer
Vlad
edited on Jun 05, 2018
Coach
McKinsey / Accenture Alum / Got all BIG3 offers / Harvard Business School
Hi,
Hi,
I recommend starting with clarifying the objective - Which metrics you need to achieve with the product? Most probably it will be ROI.
I would also clarify whether it's our painkiller on the market or the product of the competitors since competition and cannibalization are the two different cases. Then I will follow up with the structure:
Analyze our product:
- The value proposition of a product compared to the painkiller
- Different use cases of a product compared to the painkiller
- Unit economics (Current unit costs and costs in relation to scale, Investments, ROI targets, Competitor / substitutes pricing)
- Key capabilities to compete (Patent, distribution, etc)
Analyze the market:
- Size and growth rates of the painkiller market
- Size and growth rate of headache drugs
- Regulation - are they both OTC? Prescribed? Is it different by geography?
Analyze the competitors:
- Market shares, growth rates, profits
- Product (Value proposition)
- Unit economics (Value proposition vs. price vs. costs)
- Key capabilities (Distribution, supply, assets, knowledge, etc)
investment decision:
- Costs, benefits, and investments
- ROI
- Risks
Best!
0 comments
Sidi
on Jun 05, 2018
Coach
McKinsey Senior EM & BCG Consultant | Interviewer at McK & BCG for 7 years | Coached 500+ candidates secure MBB offers
Hi Anonymous,
the new drug should be launched if the net value associated with this move exceeds the investment cost over the client's target investment horizon. Morover, Risk needs to be manageable.
So you have 4 buckets to investigate:
- Net value (expected profits of new drug + impact on profits of current painkiller (potential cannibalization!))
- Investment Horizon
- Investment need for launch of the new drug
- Wider risks associated with the new drug (regulation? competitive responses? consumer sentiment?...)
Cheers, Sidi
Similar Questions
Most Popular Posts
Should I take this offer ?
19
on Dec 08, 2025
Canada
8
100+
Top answer by
Kacper
Coach
Engagement Manager | Mock interview | Problem Structuring | MECEness | Fit Q&A | Winning CV | +20 min FREE
8 Answers
100+ Views
+5
Can you negotiate your position level at MBB?
15
on Dec 10, 2025
Europe
7
100+
Top answer by
Ariadna
Coach
BCG London | Project Leader and Experienced Interviewer | MBA at London Business School
7 Answers
100+ Views
+4
How Do Consultants Think So Clearly? Looking for Tips on Articulation + Logic
9
on Dec 11, 2025
Global
7
100+
Top answer by
Giacomo Lapo
Coach
ex-McK | case & assessment prep | CV & cover letter review | tailored coaching and feedback || Get offer-ready fast!
7 Answers
100+ Views
+4
Ghosted after BCG R1?
10
on Dec 11, 2025
Asia
6
100+
Top answer by
Rodrigo
Coach
7+ years at BCG - Project Leader | Top-rated interviewer with 150+ Interviews | Genuine Commitment to your success
6 Answers
100+ Views
+3
How to Prepare for Case Interviews Without a Coach or Partner
11
on Dec 11, 2025
Global
7
100+
Top answer by
Luca
Coach
Buy 1 get 1 free for 1st time clients | 3+ years MBB experience
7 Answers
100+ Views
+4